U-IKT

Q:IKT - INHIBIKASE THERAPEUTICS INC - https://www.inhibikase.com

20:41:21 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
IKT - Q	0.1	1.42	·	1.72	0.1	1.58	+0.21	15.3	79.1	108	290	1.44 1.61 1.42	4.3503 0.79	18:26:20	Apr 18	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 290

More trades...

Time ET	Ex	Price	Change	Volume
18:26:20	Q	1.5799	0.2099	100
17:27:51	Q	1.55	0.18	20
16:44:13	Q	1.60	0.23	100
16:00:01	Q	1.58	0.21	1
16:00:01	Q	1.58	0.21	101
15:59:55	Q	1.58	0.21	100
15:59:51	Q	1.57	0.20	100
15:59:50	Q	1.56	0.19	100
15:59:50	Q	1.56	0.19	100
15:59:50	Q	1.56	0.19	100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2024-04-18 16:30	U:IKT	News Release200	Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
2024-04-03 08:05	U:IKT	News Release200	Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension
2024-03-27 16:15	U:IKT	News Release200	Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity

Date ET

Symbol

Type

Headline

2024-04-18 16:30

U:IKT

News Release

Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs

2024-04-03 08:05

U:IKT

News Release

Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension

2024-03-27 16:15

U:IKT

News Release

Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity